ERBB2 and breast cancer: Despite the widespread adoption of trastuzumab-based cancer therapies in the treatment of early stage HER2+ breast cancer, the optimal frequency of cardiac imaging is unknown, with most guidelines recommending either 3- or 4-monthly cardiac imaging [6,8,15].